Founded by two UC Berkeley graduates, DNAlite Therapeutics has been backed by the university and its Berkeley Catalyst Fund.

ICL spinout Cagen raised an undisclosed sum from Imperial Innovations and UKI2S to commercialise protein nanocages for shielding therapeutic payloads.

The corporate has led a $49.8m pre-series A round for Suiyuan Technology, which will use the proceeds for research and development.

The critical care data analytics technology developer was founded in 2017 and has its system in testing on 200 hospital beds in the Michigan Medicine centre.